View in EDS

Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial.

Saved in:
Bibliographic Details
Title: Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial.
Authors: Xiao, Wei-Wei1,2 (AUTHOR), Chen, Gong1,3 (AUTHOR), Gao, Yuan-Hong1 (AUTHOR), Lin, Jun-Zhong1,3 (AUTHOR), Wu, Xiao-Jun1,3 (AUTHOR), Luo, Hui-Long1 (AUTHOR), Lu, Zhen-Hai3 (AUTHOR), Wang, Qiao-Xuan1 (AUTHOR), Sun, Rui1 (AUTHOR), Cai, Pei-Qiang4 (AUTHOR), Zhu, Chong-Mei5 (AUTHOR), Liu, Min6 (AUTHOR), Li, Ji-Bin7 (AUTHOR), Wang, Yi-Rui1 (AUTHOR), Jin, Ying8 (AUTHOR), Wang, Feng8 (AUTHOR), Luo, Hai-Tao9 (AUTHOR), Li, Cai-Ling9 (AUTHOR), Pan, Zhi-Zhong1,3 (AUTHOR), Xu, Rui-Hua1,8 (AUTHOR) xurh@sysucc.org.cn
Source: Cancer Cell. Sep2024, Vol. 42 Issue 9, p1570-1570. 1p.
Database: Academic Search Ultimate
Description
ISSN:15356108
DOI:10.1016/j.ccell.2024.07.004